- Amended Statement of Ownership (SC 13G/A)
June 10 2009 - 12:11PM
Edgar (US Regulatory)
|
|
|
|
UNITED
STATES
|
|
|
SECURITIES
AND EXCHANGE COMMISSION
|
|
|
Washington,
D.C. 20549
|
|
|
|
|
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment No. 1)*
OSI
Pharmaceuticals, Inc.
(Name of Issuer)
(Title of Class of
Securities)
(CUSIP Number)
(Date of Event
Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
x
|
Rule 13d-1(b)
|
o
|
Rule 13d-1(c)
|
o
|
Rule 13d-1(d)
|
*The remainder of this cover page shall be filled out for a reporting
persons initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
CUSIP No. 671040103
|
|
|
1.
|
Names of Reporting Persons
Lord, Abbett & Co. LLC
|
|
|
2.
|
Check the Appropriate Box
if a Member of a Group (See Instructions)
|
|
|
(a)
|
o
|
|
|
(b)
|
o
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
2,362,312
|
|
6.
|
Shared Voting Power
0
|
|
7.
|
Sole Dispositive Power
2,571,346
|
|
8.
|
Shared Dispositive Power
0
|
|
|
9.
|
Aggregate Amount
Beneficially Owned by Each Reporting Person
2,571,367
|
|
|
10.
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions)
o
N/A
|
|
|
11.
|
Percent of Class
Represented by Amount in Row (9)
4.44%
|
|
|
12.
|
Type of Reporting Person
(See Instructions)
IA
|
|
|
|
|
|
|
2
Item 1.
|
|
(a)
|
Name of Issuer
OSI Pharmaceuticals, Inc.
|
|
(b)
|
Address of Issuers
Principal Executive Offices
41 Pinelawn Road
Melville, NY 11747
|
|
Item 2.
|
|
(a)
|
Name of Person Filing
Lord, Abbett & Co. LLC.
|
|
(b)
|
Address of Principal
Business Office or, if none, Residence
90 Hudson Street
Jersey City, NJ 07302.
|
|
(c)
|
Citizenship
See No. 4 on page 2.
|
|
(d)
|
Title of Class of
Securities
See cover page.
|
|
(e)
|
CUSIP Number
See cover page.
|
|
Item 3.
|
If this statement is filed pursuant
to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is
a:
|
|
(a)
|
o
|
Broker or dealer
registered under section 15 of the Act (15 U.S.C. 78o);
|
|
(b)
|
o
|
Bank as defined in section
3(a)(6) of the Act (15 U.S.C. 78c);
|
|
(c)
|
o
|
Insurance company as
defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
|
(d)
|
o
|
Investment company
registered under section 8 of the Investment Company Act of 1940 (15 U.S.C.
80a-8);
|
|
(e)
|
x
|
An investment adviser in
accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
o
|
An employee benefit plan
or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
o
|
A parent holding company
or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
o
|
A savings association as
defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813);
|
|
(i)
|
o
|
A church plan that is
excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
o
|
A non-U.S. institution in
accordance with § 240.13d1(b)(1)(ii)(J);
|
|
(k)
|
o
|
Group, in accordance with
§ 240.13d1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance
with § 240.13d1(b)(1)(ii)(J), please specify the type of
institution:____________________________
|
3
Item 4.
|
Ownership
|
Provide the following
information regarding the aggregate number and percentage of the class of
securities of the issuer identified in Item 1.
|
|
(a)
|
Amount beneficially
owned:
See No. 9 on page 2.
|
|
(b)
|
Percent of class:
See No. 11 on page 2.
|
|
(c)
|
Number of shares as to
which the person has:
|
|
|
(i)
|
Sole power to vote or to
direct the vote
See No. 5 on page 2.
|
|
|
(ii)
|
Shared power to vote or to
direct the vote
See No. 6 on page 2.
|
|
|
(iii)
|
Sole power to dispose or
to direct the disposition of
See No. 7 on page 2.
|
|
|
(iv)
|
Shared power to dispose or
to direct the disposition of
See No. 8 on page 2.
|
|
Item 5.
|
Ownership of Five Percent or Less
of a Class
|
If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of securities, check
the following
x
.
|
|
Item 6.
|
Ownership of More than Five Percent
on Behalf of Another Person
|
Securities reported on this Schedule 13G as being
beneficially owned by Lord, Abbett & Co. LLC are held on behalf on
investment advisory clients, which may include investment companies
registered under the Investment Company Act, employee benefit plans, pension
funds or other institutional clients.
Not applicable.
|
|
Item 7.
|
Identification and Classification
of the Subsidiary Which Acquired the Security Being Reported on By the Parent
Holding Company or Control Person
|
Not applicable.
|
|
Item 8.
|
Identification and Classification
of Members of the Group
|
Not applicable.
|
|
Item 9.
|
Notice of Dissolution of Group
|
Not applicable.
|
4
Item 10.
|
Certification
|
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that
purpose or effect.
|
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
|
June 10, 2009
|
|
Date
|
|
/s/ Lawrence H. Kaplan
|
|
Signature
|
|
Lawrence H. Kaplan/General Counsel
|
|
Name/Title
|
5
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jul 2024 to Aug 2024
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Aug 2023 to Aug 2024